Intrinsic Value of S&P & Nasdaq Contact Us

Pacific Biosciences of California, Inc. PACB NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
41/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.74
+74.6%

Stock Statistics — PACB

Pacific Biosciences of California, Inc. (PACB) has a market capitalization of $473.83M and trades at $1.57. The 52-week range is 0.85-2.73.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.9, Earnings Per Share (EPS) of $-1.82, annual revenue of $160.01M.

The stock has a beta of 2.33, operates in the Healthcare sector.

Trading Data
Current Price$1.57
52-Week Range0.85-2.73
Volume6.24M
Avg Volume (30D)6.55M
Market Cap$473.83M
Beta (1Y)2.33
Company
IPO Date2010-10-27
Employees575
CEOChristian O. Henry
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS69404D1081
CUSIP69404D108
Income (Latest Year)
Revenue$160.01M
Gross Profit$50.67M
EBITDA$-34.2M
Operating Income$-557.56M
Net Income$-546.38M
EPS$-1.82
EPS Diluted$-1.82
Shares Outstanding$299.96M
Balance Sheet (Latest Year)
Total Assets$784.08M
Current Assets$375.03M
Cash & ST Investments$279.51M
Total Liabilities$778.73M
Total Debt$759.46M
Net Debt$695.76M
Total Equity$5.35M
Debt / Equity141.98
Valuation Ratios
P/E Ratio-0.9
P/S Ratio2.96
P/B Ratio88.58
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message